UNSPSC 51282904: Balofloxacin

This classification denotes a quinolone antibiotic with the molecular formula C20H24FN3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q022B63JPM, chemically known as 3-quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-(methylamino)-1-piperidinyl)-4-oxo- but generally known as balofloxacin, which bears US NIH Compound Identifier 65958. Balofloxacin most often comes in base and hydrate forms.

UNSPSC 51282904 Balofloxacin is a Commodity code nominally designating a specific antibiotic pharmaceutical, but recent state and local procurement activity under this code does not reflect purchases of balofloxacin itself. Instead, the code appears in solicitations for naloxone (an opioid-overdose reversal agent), medical and first aid supplies for emergency response, and generic multi-source pharmaceuticals and over-the-counter products distributed through state and local health systems and cooperative purchasing arrangements. The actual work being solicited involves procurement of pharmaceuticals and emergency medical supplies by state health agencies, county health departments, and municipal fire departments through competitive bidding, RFPs, and cooperative purchasing vehicles. Issuing bodies include the Seminole County, Florida Community Health Department, the Texas Health and Human Services Commission, the City of Tampa Fire Department, and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) on behalf of participating state and local facilities. The mismatch between the code's nominal scope and recent activity suggests the code may be used as a catch-all for pharmaceutical procurement rather than a targeted identifier for balofloxacin specifically.

Recent opportunities span Florida, Texas, Minnesota, and Oregon through cooperative purchasing. Seminole County issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023 (note: date inconsistency in source), for quarterly delivery to the Seminole County Community Health Building. The City of Tampa issued ITB 26P00145 in March 2026 for medical and first aid supplies across 169 line items for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000.00 and a sheltered-market set-aside for certified Small Local Business Enterprises offering a 5 percent bid discount. The Texas Health and Human Services Commission issued RFI HHS0017013 in April 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program. MMCAP issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products, with proposals due March 26, 2026, requiring vendor compliance with cGMP, DSCSA certification, and a 3 percent administrative fee structure.